Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

tuberactinomycin

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Viomycin is a tuberactinomycin antibiotic essential for treating multidrug-resistant tuberculosis. It inhibits bacterial protein… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2008
2008
Translocation during the elongation phase of protein synthesis involves the relative movement of the 30S and 50S ribosomal… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 2
Is this relevant?
2007
2007
The nonproteinogenic amino acid capreomycidine is the signature residue found in the tuberactinomycin family of antitubercular… Expand
Is this relevant?
2003
2003
The tuberactinomycin antibiotics are essential components in the drug arsenal against Mycobacterium tuberculosis infections and… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
1995
1995
Several examples of inhibition of the function of a ribozyme or RNA-protein complex have shown that certain antibiotics can… Expand
Is this relevant?
1994
1994
The tuberactinomycins are a group of cyclic peptide antibiotics, which are potent inhibitors of prokaryotic protein synthesis. We… Expand
Is this relevant?
1985
1985
The binding of 14C-labelled tuberactinomycin O was analysed in equilibrium dialysis cells. The ionic conditions and the… Expand
Is this relevant?
1978
1978
Abstract The binding of [ 14 C]tuberactinomycin O, an antibiotic closely related to viomycin, to E. coli ribosomes has been… Expand
Is this relevant?
1975
1975
Phenotypes of isolates of Mycobacterium tuberculosis H37RV showing resistance to the aminoglucoside antibiotics streptomycin… Expand
  • table I
  • table 2
  • table 3
Is this relevant?
1969
1969
 
Is this relevant?